Can you take NAD+ / NMN / NR and Resveratrol together?

The available evidence is use- and population-specific. Each page documents mechanism, studied or reported dose context, risks, and legal status; the database does not determine whether a combination is appropriate for an individual.

Rankings / Comparisons

NAD+ / NMN / NR vs Resveratrol

The classic NAD+ vs sirtuin-activator debate — different pathways aimed at the same aging hallmark.

Reviewed by Read Off Label · How we grade

Score comparison

NAD+ / NMN / NR has the higher descriptive composite (B+, 7.1/10) compared with Resveratrol (B-, 6.2/10). The axes below show whether that difference comes from evidence, reported benefit, safety, or a combination.

NAD+ / NMN / NR

B+ 7.1/10

aka Nicotinamide mononucleotide, Nicotinamide riboside, Niagen

Evidence: Moderate (raises NAD+ reliably); Weak (functional/outcome endpoints) (6/10)
Benefit: Varies (5/10)
Risk: Low (9/10 safety)
Legality: OTC
Dose / route context: 250-1000 mg/day NMN or NR (sublingual or oral); IV NAD+ infusions also used
Class: Supplement
Last reviewed: Aug 2, 2026

Read Off Label grades NAD+ / NMN / NR as B+ (7.1/10) based on moderate evidence, variable benefit magnitude, and a low-risk safety profile.

Yoshino 2021: NMN 250 mg/day improved muscle insulin sensitivity 25% in prediabetic women.

Studied, labeled, or reported-use context: 250-1000 mg/day NMN or NR (sublingual or oral); IV NAD+ infusions also used — OTC; not individualized guidance.

What it is

Yoshino 2021: NMN 250 mg/day improved muscle insulin sensitivity 25% in prediabetic women. Multiple RCTs show elevated NAD+ but inconsistent functional outcomes (strength, cognition, CV markers). Boosting NAD+ is easy; demonstrating clinical benefit is not. Phase II randomised placebo-controlled pilot in amnestic mild cognitive impairment (Alzheimer's & Dementia, Jul 2026; n=42 completers, 12 weeks): nicotinamide riboside doubled blood NAD with no serious adverse effects, but produced no improvement in cognitive function (primary outcome), total cerebral blood flow, or blood pressure. Exploratory analysis suggested possible regional cerebral-blood-flow increases in the hippocampus. A direct illustration of the row's existing split: raising NAD+ is reliable, translating that into a functional outcome is not.

Mechanism

Precursors to NAD+ — essential cofactor for sirtuins (SIRT1-7), PARPs, CD38; ETC; cellular NAD+ declines with age

Full NAD+ / NMN / NR review →

Resveratrol

B- 6.2/10

Evidence: Weak-Moderate (4.5/10)
Benefit: Low-Med (3.5/10)
Risk: Low (9/10 safety)
Legality: OTC
Dose / route context: 150-500 mg/day trans-resveratrol; micronized formulations and co-administration with fat appear in absorption studies
Class: Supplement
Last reviewed: Jul 11, 2026

Read Off Label grades Resveratrol as B- (6.2/10) based on weak-moderate evidence, low-med benefit magnitude, and a low-risk safety profile.

Oft-cited as foundational longevity compound but human RCTs largely unimpressive.

Studied, labeled, or reported-use context: 150-500 mg/day trans-resveratrol; micronized formulations and co-administration with fat appear in… — OTC; not individualized guidance.

What it is

Oft-cited as foundational longevity compound but human RCTs largely unimpressive. Poor bioavailability (~1%). Metabolites may be active. 2025 meta-analysis: no significant SIRT1 effect in humans. Popularity persists despite modest signals.

Mechanism

Trans-resveratrol proposed SIRT1 activator (debated — likely indirect); AMPK activation; anti-inflammatory; vascular endothelial effects; poor oral bioavailability

Full Resveratrol review →

Common questions

How do the evidence profiles of NAD+ / NMN / NR and Resveratrol compare?: NAD+ / NMN / NR has the higher descriptive composite (B+, 7.1/10) compared with Resveratrol (B-, 6.2/10). The axes below show whether that difference comes from evidence, reported benefit, safety, or a combination.
What's the difference between NAD+ / NMN / NR and Resveratrol?: The classic NAD+ vs sirtuin-activator debate — different pathways aimed at the same aging hallmark.
Can you take NAD+ / NMN / NR and Resveratrol together?: The available evidence is use- and population-specific. Each page documents mechanism, studied or reported dose context, risks, and legal status; the database does not determine whether a combination is appropriate for an individual.

This is an independent synthesis of published research by a non-clinician. The comparison reports composite and axis-level differences without selecting an intervention for the reader. Relevance depends on indication, population, dose, duration, and other context. See the full disclaimer and methodology.